Form 4 for NEO NEOGENOMICS INC
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-15 · accession 0001077183-24-000162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | NEO | Olivo Alicia C | GC | S - Sale | $15.36 | -5,175 | 37.1K | -12% | -$79.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-15 | S | D | 5,175 | $15.36 | 37,129 | D | — | — | (F2) This balance includes 157 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3. |